PARIS, France—A new analysis of more than 10,000 patients likely slams the door on routinely using cerebral embolic protection for stroke prevention in patients with aortic stenosis undergoing TAVI.

BOSTON, MA—Those who were hoping that PROTECTED TAVR would provide a clear-cut result and bring closure to the question of whether cerebral embolic protection (CEP) reduces stroke in patients ...

A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...

Please provide your email address to receive an email when new articles are posted on . BOSTON — In PROTECTED TAVR, the largest-ever randomized trial of transcatheter aortic valve replacement, ...

Please provide your email address to receive an email when new articles are posted on . Routine cerebral embolic protection did not reduce stroke in patients undergoing transcatheter aortic valve ...

Elective carotid artery angioplasty and stenting was initiated in the United States in 1994 by the endovascular interventional team at the University of Alabama at Birmingham. Carotid stenting was ...

Transcatheter aortic-valve replacement (TAVR) for the treatment of aortic stenosis can lead to embolization of debris. Capture of debris by devices that provide cerebral embolic protection (CEP) may ...

EmStop has completed the ‘Controlled Arterial Protection to Ultimately Remove Embolic Material’ (CAPTURE-1) early feasibility clinical study which assessed the EmStop embolic protection system. The ...

SAN FRANCISCO (MarketWatch) -- Boston Scientific Corp. on Monday said two studies showed a composite 98.1% procedural success rate by its second-generation FilterWire EZ Embolic Protection System in ...

A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...